TCL Archive NCI Supercomputer Upgrading Supported By DCBD Board; Could Cost $40 Million Plus Renovations March 3, 1989
TCL Archive Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says September 26, 2014
TCL Archive Study Would Try to Validate EGFR FISH as Predictive Marker for Benefit from Tarceva. July 13, 2007